16 jul 2012 año - FDA Approves Truvada
Descripción:
On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved the use of Truvada® (a fixed dose combination of emtricitabine/tenofovir disoproxil fumarate) as a pre-exposure prophylaxis (PrEP) for HIV-negative individuals who are at high risk of acquiring HIV.Añadido al timeline:
fecha:
16 jul 2012 año
Ahora mismo
~ 12 years ago